Fiche du document
1 juin 2011
- handle: 10670/1.z3ggcn
Ce document est lié à :
10.4067/S0718-27242011000200001
info:eu-repo/semantics/openAccess
Sujets proches
Drug trade Drug industryCiter ce document
Jingxi Ding et al., « From Imitation to Innovation: A Study of China's Drug R&D and Relevant National Policies », Journal of Technology Management & Innovation, ID : 10670/1.z3ggcn
Métriques
Partage / Export
Résumé
Research & Development (R&D) plays an increasingly important role in China's pharmaceutical industry. To gain a competitive edge in the global pharmaceutical market, the current national strategy of China forcefully pushes for independent drug innovations. This article investigates the historical, legal, and institutional contexts in which China's drug R&D has evolved. Based on an analysis of the drug R&D evolution and national policies in China, it predicts the future trend of China's policies relevant to drug innovations. This paper helps to understand the impact of national policies on drug R&D in China, which can be used to inform decision-making on investments in China's pharmaceutical market or conducting technology trade and international cooperation with Chinese partners.